Pluri Inc. Common Stock

PLURNASDAQUSD
1.64 USD
0.08 (5.13%)🟢PRE MARKET (AS OF 07:19 AM EDT)
🟢Market: OPEN

Shares of Pluri Inc. Common Stock (PLUR) are trading at $1.64. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (140.5%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Aug 4, 2026.

Open?$1.56
High?$1.64
Low?$1.55
Prev. Close?$1.56
Volume?560
Avg. Volume?37.1K
VWAP?$1.63
Rel. Volume?0.02x
Bid / Ask
Bid?$1.34 × 100
Ask?$1.78 × 100
Spread?$0.44
Midpoint?$1.56
Valuation & Ratios
Market Cap?16.8M
Shares Out?10.8M
Float?6.1M
Float %?56.1%
P/E Ratio?N/A
P/B Ratio?-0.93
EPS?-$2.37
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
Employees
142
Market Cap
17.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
1991-10-09
Address
MATAM ADVANCED TECHNOLOGY PARK
HAIFA,
Phone: 972-74-710-7171
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-3/3)
Short-Term (Ripple)? Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
0
Momentum?
10
Short Sent.?
80
Piotroski F-Score?3/9Weak
Altman Z-Score?-28.76Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.40%Low
Short Interest?24.0K
Days to Cover?1.0
Free Float6.1M
Avg Daily Volume67.3K
Settlement Date2026-07-15
Financial Health
Current Ratio?0.32Weak
Quick Ratio?0.32Weak
Cash Ratio?0.11Low
Debt/Equity?-1.51Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
S&P
97
-0.93CHEAP
P/S?
Peers
100
S&P
3
15.60HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-1.6CHEAP
EV/Sales?
Peers
100
S&P
3
37.84HIGH
Returns & Efficiency
ROE?
Peers
50
S&P
97
140.5%STRONG
ROA?
S&P
3
-98.0%WEAK
Cash Flow & Enterprise
FCF?$-22036000
Enterprise Value?$40.8M
Fundamentals ratios updated end of day